Cobomarsen
- Generic Name
- Cobomarsen
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1848257-52-2
- Unique Ingredient Identifier
- 3JKW7CI9IU
- Background
Cobomarsen is under investigation in clinical trial NCT02580552 (Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL).
- Associated Conditions
- -
- Associated Therapies
- -
PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- miRagen Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03837457
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
๐ซ๐ทHopital Saint Andre, CHU de Bordeaux, Bordeaux, France
๐บ๐ธUniversity of Washington/Seattle Cancer Care Alliance, Seattle, Washington, United States
SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides
- Conditions
- Interventions
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- miRagen Therapeutics, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT03713320
- Locations
- ๐บ๐ธ
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
๐บ๐ธInova Schar Cancer Institute, Fairfax, Virginia, United States
๐บ๐ธDana Farber Cancer Institute, Boston, Massachusetts, United States
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
- First Posted Date
- 2015-10-20
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- miRagen Therapeutics, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT02580552
- Locations
- ๐บ๐ธ
UCLA Department of Medicine, Los Angeles, California, United States
๐บ๐ธUniversity of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
๐บ๐ธThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.